OPK OPKO HEALTH INC revenue, earnings and financials
For the quarter ended June 30, 2026, OPKO HEALTH INC reported revenue of $164M (up 4.3% from a year earlier), net income of −$8.42M and diluted EPS of −$0.01; over the last four quarters revenue was $588M and net income −$72.9M; for the fiscal year ended December 2025 revenue was $607M, down 14.9% on the year before.
OPK annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $607M, gross profit $206M, operating income −$117M, net income −$226B (margin -37187.0%), EPS −$0.30
- Fiscal year ended Dec 2024: revenue $713M, gross profit $219M, operating income −$152M, net income −$53.2B (margin -7463.3%), EPS −$0.08
- Fiscal year ended Dec 2023: revenue $863M, gross profit $318M, operating income −$157M, net income −$189B (margin -21871.9%), EPS −$0.25
- Fiscal year ended Dec 2022: revenue $1.00B, gross profit $288M, operating income −$226M, net income −$328B (margin -32703.3%), EPS −$0.46
- Fiscal year ended Dec 2021: revenue $1.77B, gross profit n/a, operating income $18.8M, net income −$30.1B (margin -1698.5%), EPS −$0.05
OPK quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $164M (up 4.3% year over year), net income −$8.42M, EPS −$0.01
- Quarter ended Mar 31, 2026: revenue $124M (down 17.2% year over year), net income −$54.8M, EPS −$0.07
- Quarter ended Dec 31, 2025: revenue $148M (down 19.2% year over year), net income −$31.3M, EPS −$0.04
- Quarter ended Sep 30, 2025: revenue $152M (down 12.6% year over year), net income $21.6M, EPS $0.03
- Quarter ended Jun 30, 2025: revenue $157M (down 13.9% year over year), net income −$148M, EPS −$0.19
- Quarter ended Mar 31, 2025: revenue $150M (down 13.7% year over year), net income −$67.6M, EPS −$0.10
- Quarter ended Dec 31, 2024: revenue $184M (up 1.0% year over year), net income $14.0M, EPS $0.01
- Quarter ended Sep 30, 2024: revenue $174M (down 2.8% year over year), net income $24.9M, EPS $0.03
- Quarter ended Jun 30, 2024: revenue $182M (down 31.4% year over year), net income −$10.3M, EPS −$0.01
- Quarter ended Mar 31, 2024: revenue $174M (down 26.9% year over year), net income −$81.8M, EPS −$0.12
- Quarter ended Dec 31, 2023: revenue $182M (down 1.9% year over year), net income −$66.5M, EPS n/a
- Quarter ended Sep 30, 2023: revenue $179M (down 0.6% year over year), net income −$84.5M, EPS −$0.11
- Quarter ended Jun 30, 2023: revenue $265M (down 14.4% year over year), net income −$19.6M, EPS n/a
- Quarter ended Mar 31, 2023: revenue $238M (down 27.8% year over year), net income −$18.3M, EPS −$0.02
- Quarter ended Dec 31, 2022: revenue $185M (down 53.8% year over year), net income −$85.2M, EPS −$0.11
- Quarter ended Sep 30, 2022: revenue $180M (down 53.4% year over year), net income −$86.1M, EPS −$0.11
- Quarter ended Jun 30, 2022: revenue $310M (down 30.0% year over year), net income −$102M, EPS −$0.14
- Quarter ended Mar 31, 2022: revenue $329M (down 39.6% year over year), net income −$55.4M, EPS −$0.08
- Quarter ended Dec 31, 2021: revenue $401M, net income −$73.8M, EPS −$0.11
- Quarter ended Sep 30, 2021: revenue $386M, net income $28.7M, EPS $0.04
OPK cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$179M, share buybacks $47.0M
- Fiscal year ended Dec 2024: operating cash flow −$183M, share buybacks $90.2M
- Fiscal year ended Dec 2023: operating cash flow −$28.2M, share buybacks $0
- Fiscal year ended Dec 2022: operating cash flow −$95.2M, share buybacks $0
- Fiscal year ended Dec 2021: operating cash flow $38.3M, share buybacks n/a
OPK balance sheet
- Jun 30, 2026: cash $301M, total assets $1.83B, total liabilities $645M, shareholders' equity $1.18B, long-term debt $1.78M
- Mar 31, 2026: cash $332M, total assets $1.86B, total liabilities $652M, shareholders' equity $1.20B, long-term debt $2.01M
- Dec 31, 2025: cash $364M, total assets $1.93B, total liabilities $664M, shareholders' equity $1.27B, long-term debt $2.26M
- Sep 30, 2025: cash $412M, total assets $2.00B, total liabilities $690M, shareholders' equity $1.31B, long-term debt $2.51M
- Jun 30, 2025: cash $267M, total assets $1.97B, total liabilities $676M, shareholders' equity $1.30B, long-term debt $2.77M
- Mar 31, 2025: cash $429M, total assets $2.13B, total liabilities $817M, shareholders' equity $1.31B, long-term debt $2.83M
- Dec 31, 2024: cash $427M, total assets $2.20B, total liabilities $835M, shareholders' equity $1.37B, long-term debt $3.00M
- Sep 30, 2024: cash $400M, total assets $2.26B, total liabilities $853M, shareholders' equity $1.40B, long-term debt $3.53M
What is OPK's revenue?
OPKO HEALTH INC reported $588M of revenue over its last four quarters, through June 30, 2026.
Is OPK profitable?
No. OPKO HEALTH INC lost $72.9M over the last four quarters.
What is OPK's EPS?
Diluted earnings per share over the last four quarters were −$0.09; −$0.01 in the latest quarter.